-+ 0.00%
-+ 0.00%
-+ 0.00%

NeuroSense Therapeutics Reports Reduced Net Loss of $4.7M in H1 2025, EPS Improves to $(0.19)

Reuters·08/01/2025 13:00:57

Please log in to view news